Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$596.92 USD

596.92
2,138,161

+3.13 (0.53%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

PayPal (PYPL) to Report Q2 Earnings: What's in the Offing?

PayPal's (PYPL) second-quarter results are likely to benefit from strong product portfolio and strategic partnerships.

ASGN to Report Q2 Earnings: What's in Store for the Stock?

ASGN's second-quarter results are likely to be perked up by broad-based segmental growth.

F5 Networks (FFIV) to Report Q3 Earnings: What's in Store?

Growth in software solutions is likely to aid F5 Networks' (FFIV) third-quarter fiscal 2019 results. However, slowdown in systems business is a persistent downside.

TE Connectivity (TEL) to Post Q3 Earnings: What's in Store?

TE Connectivity's (TEL) industrial and communications solutions portfolio is likely to aid fiscal Q3 results. Yet, weak market conditions in China & softness in European Auto may mar top-line growth.

Will 2-Pronged Plan Aid Quest Diagnostics (DGX) Q2 Earnings?

Quest Diagnostics' (DGX) frequent partnership wins with health care leaders and sensible buyouts are creating bountiful opportunities for the top and the bottom line.

Trina Mukherjee headshot

IVD Market Sustains Momentum: 3 Stocks in Focus

In-vitro Diagnostics has successfully proven itself to be the best diagnostic procedures. So, investors can add stocks from this space to their watchlist.

Can Product Strength Aid Texas Instruments (TXN) Q2 Earnings?

We do not expect Texas Instruments (TXN) to perform well in Q2 owing to weakness in demand and an uncertain macro environment. However, strength in analog & embedded markets might aid results.

Abbott (ABT) Tops Q2 Earnings Estimates, Lifts EPS Guidance

Abbott (ABT) registers strong Cardiovascular and Neuromodulation sales on double-digit growth in Electrophysiology, Heart Failure and Structural Heart.

Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Abbott's (ABT) Q2 Earnings Gain From Overall Growth?

Abbott's (ABT) consistent rise on a strong Diabetes Care business performance is seen over the last few quarters.

The Zacks Analyst Blog Highlights: Northrop Grumman, Thermo Fisher Scientific, Newmont Goldcorp, Starbucks and CME

The Zacks Analyst Blog Highlights: Northrop Grumman, Thermo Fisher Scientific, Newmont Goldcorp, Starbucks and CME

Nalak Das headshot

Can Fed Put Counter Potential Negative Q2 Earnings? 5 Picks

Fed's rate cut will not only make cheaper funds available to businesses and stock market investors, but also U.S. dollar less expensive in the international market.

Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report?

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The Zacks Analyst Blog Highlights: JPMorgan, Thermo Fisher, Broadcom, Marriott and Global Payments

The Zacks Analyst Blog Highlights: JPMorgan, Thermo Fisher, Broadcom, Marriott and Global Payments

Mark Vickery headshot

Top Stock Reports for JPMorgan, Thermo Fisher & Broadcom

Today's Research Daily features new research reports on 16 major stocks, including JPMorgan (JPM), Thermo Fisher (TMO) and Broadcom (AVGO).

Thermo Fisher's Unit Sale May Not Ail Specialty Diagnostics

The Anatomical Pathology business of Thermo Fisher (TMO) belongs to its Specialty Diagnostics segment that serves customers across healthcare and clinical laboratories.

Thermo Fisher Abandons Gatan Deal in Want of European Nod

Thermo Fisher (TMO) and Roper will carry on with their current long-term supply agreement.

Why Is Thermo Fisher (TMO) Up 0.6% Since Last Earnings Report?

Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Thermo Fisher Acquires GlaxoSmithKline's Drug Production Site

The latest acquisition aligns with Thermo Fisher's (TMO) strategy of enhancing capabilities of its Pharma Services through the right balance of capital investment, and merger and acquisition.

Is Thermo Fisher Scientific (TMO) Stock Outpacing Its Medical Peers This Year?

Is (TMO) Outperforming Other Medical Stocks This Year?

Thermo Fisher Scientific Sees Hammer Chart Pattern: Time to Buy?

Thermo Fisher Scientific Inc. (TMO) has been struggling lately, but the selling pressure may be coming to an end soon.

The Zacks Analyst Blog Highlights: Mastercard, PayPal, Thermo Fisher, Starbucks and Simon Property

The Zacks Analyst Blog Highlights: Mastercard, PayPal, Thermo Fisher, Starbucks and Simon Property

Mark Vickery headshot

Top Research Reports for Mastercard, PayPal & Thermo Fisher

Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), PayPal (PYPL) and Thermo Fisher (TMO).

Zacks.com featured expert Kevin Matras highlights: Foot Locker, Thermo Fisher Scientific, SS&C Technologies, Columbia Sportswear and Comcast

Zacks.com featured expert Kevin Matras highlights: Foot Locker, Thermo Fisher Scientific, SS&C Technologies, Columbia Sportswear and Comcast

Thermo Fisher (TMO) Beats on Q1 Earnings, Raises '19 View

Thermo Fisher (TMO) reports strong Laboratory Products and Services performance, flaunting robust global demand.